GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.

Published

Journal Article

We present guidelines to standardize the reporting of phase 1 and phase 2 neuro-oncology trials. The guidelines are also intended to assist with accurate interpretation of results from these trials, to facilitate the peer-review process, and to expedite the publication of important and accurate manuscripts. Our guidelines are summarized in a checklist format that can be used as a framework from which to construct a phase 1 or 2 clinical trial.

Full Text

Duke Authors

Cited Authors

  • Chang, SM; Reynolds, SL; Butowski, N; Lamborn, KR; Buckner, JC; Kaplan, RS; Bigner, DD

Published Date

  • October 2005

Published In

Volume / Issue

  • 7 / 4

Start / End Page

  • 425 - 434

PubMed ID

  • 16212807

Pubmed Central ID

  • 16212807

International Standard Serial Number (ISSN)

  • 1522-8517

Digital Object Identifier (DOI)

  • 10.1215/S1152851705000554

Language

  • eng

Conference Location

  • England